Drawing for BIOCHEM PHARMA

USPTO serial 74250016

BIOCHEM PHARMA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
LEVINE, HOWARD B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOCHEM PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations used to treat aids, viral infections, cancer, cardiovascular problems, cholesterol; analgesics; kits consisting primarily of reagents used for the diagnosis of aids; vaccines and immunological preparations use to prevent infectious diseasesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 12, 1995ABN1ABANDONMENT - EXPRESS MAILED
Dec 7, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 1994CNSIINQUIRY AS TO SUSPENSION MAILED
Nov 19, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 1993UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED
Sep 13, 1993CNSLLETTER OF SUSPENSION MAILED
Aug 23, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 1993CNSIINQUIRY AS TO SUSPENSION MAILED
Jan 5, 1993CNSLLETTER OF SUSPENSION MAILED
Nov 18, 1992CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 1992DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance